Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

ImmuPharma initiates phase 2/3 clinical trial for lupus treatment

June 19, 2023 Research and Development Avion Pharmaceuticals, ImmuPharma, Immunology, Lupus, clinical trial

ImmuPharma has announced that it will commence a phase 2/3 adaptive clinical trial of P140 (Lupuzor) in patients with systemic …
News
document-428331_960_720

Nordic Bioscience receives FDA Letter of Support for biomarker in aggressive tumour fibrosis

June 16, 2023 Research and Development FDA, Nordic Bioscience, Oncology, Roche, tumour fibrosis

Danish biomarker company Nordic Bioscience has announced that the US Food and Drug Administration (FDA) has awarded it a Letter …
News

Takeda and HUTCHMED’s cancer drug shown to prolong overall survival

June 16, 2023 Research and Development HUTCHMED, Oncology, Takeda, colorectal cancer

Clinical trial data from a study into the metastatic colorectal cancer (CRC) drug fruquintinib, which is being developed by Japanese …
News
Antibiotics image

FDA gives Eagle Pharmaceuticals Qualified Infectious Disease Product (QIDP) and Fast-Track Designation for SCABP drug

June 15, 2023 Research and Development Eagle Pharmaceuticals, FDA, FDA fast-track, Immunology, SCABP

US-based pharmaceutical company Eagle Pharmaceuticals has announced that the US Food and Drug Administration (FDA) has granted its severe community-acquired …
News
shaking-hands-gb7ac17374_1920

Astellas and Cullgen enter into $1.9bn strategic collaboration to progress protein degraders

June 15, 2023 Research and Development Astellas, Cullgen, Oncology, protein degraders

Japanese pharmaceutical company Astellas and US-based clinical-stage biopharmaceutical company Cullgen have announced that they have entered into a strategic research …
News

Critical Path Institute receives FDA Biomarker LOS for DIPI biomarkers

June 14, 2023 Research and Development Critical Path Institute, Endocrinology, FDA, biomarkers, pancreatic injury

US-based Critical Path Institute (C-Path) has announced that the Biomarker Qualification Program (BQP) at the Center for Drug Evaluation and …
News
clinical_trials

Kymera Therapeutics reports positive data in cancer drug trials

June 14, 2023 Research and Development Cancer, Kymera Therapeutics, Oncology, autoimmune diseases, clinical trials, inflammatory diseases

US clinical-stage biopharmaceutical company Kymera Therapeutics has shared new data regarding its oncology programmes KT-333 and KT-413, highlighting their robust dose-dependent …
News

PharmAla receives MDMA research grant from Ontario Centre of Innovation

June 12, 2023 Research and Development MDMA, PharmAla, Psychiatry, in silico, research grant

Canadian biotechnology company PharmAla has announced that it has been awarded a research grant from the Ontario Centre of Innovation …
News

AstraZeneca and MSD’s Lynparza receives NICE positive recommendation as a cancer maintenance treatment

June 9, 2023 Research and Development AstraZeneca, Cancer, MSD, NICE, Oncology, lynparza, pharma

UK-based pharmaceutical company AstraZeneca has announced that the National Institute for Health and Care Excellence (NICE) posted a positive recommendation …
News
acute_lymphoblastic_leukaemia_smear

Astellas Pharma and BMT CTN announce phase 3 data for gilteritinib

June 9, 2023 Research and Development Astellas Pharma, BMT CTN, Haematology, gilteritinib, leukaemia, pharmaceutical

Japanese pharmaceutical company Astellas Pharma and the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) have presented their phase …
News
blood_tests_pic

Innate Pharma announces drug researched with Sanofi receives FDA Fast Track Designation

June 8, 2023 Research and Development Cancer, FDA, Haematology, Innate Pharma, Sanofi, haematology

Innate Pharma has announced that the drug jointly researched between itself and Sanofi has received US Food and Drug Administration (FDA) …
News
brain_anatomy_medical_head_skull_digital_3_d_x_ray_xray_psychedelic_3720x2631

Axol Bioscience and StrataStem collaborate to deliver ‘clinical trial in a dish’ for Alzheimer’s disease

June 7, 2023 Research and Development Alzheimer's, Axol Bioscience, Neurology, StrataStem

Pluripotent stem cell technology provider Axol Bioscience has signed an exclusive agreement with UK-based StrataStem to access and commercialise its …
News
weight-2036971_960_720

UK plans £40m drug trial for Novo Nordisk’s Wegovy to aid NHS in treating obesity

June 7, 2023 Research and Development NHS, Novo Nordisk, Obesity, Wegovy, clinical trial, obesity

The UK Government has announced plans to launch a pilot programme which will provide GPs with Novo Nordisk’s Wegovy (semaglutide), …
News
blood_tests_pic

GRAIL and University of Oxford showcase first prospective study results for multi-cancer early detection test

June 6, 2023 Research and Development Cancer, GRAIL, Oncology, University of Oxford, cancer testing

US-based healthcare company GRAIL and the University of Oxford, UK, have announced encouraging first prospective study results at the American …
News

ISA Pharmaceuticals highlights positive clinical data at ASCO

June 6, 2023 Research and Development ASCO, Cancer, HPV, ISA Pharmaceuticals, Oncology

Clinical stage biotechnology company ISA Pharmaceuticals has announced positive phase 1 data at the American Society of Clinical Oncology (ASCO) …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025